BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Carroucell Raises €1.5 Million to Introduce Breakthrough Microcarriers and Customizable Processes to Cell and Gene Therapy Market

  Carroucell, the microcarrier supplier for cell culture in bioreactor, announced that it has raised a total of €1.5 million.

  September 7, 2022

   · 

  3 min read
• Philips announces new milestones in the development of the world’s first spectral detector angio CT solution

  Royal Philips, a global leader in health technology, announced new milestones in the development of the world’s first spectral detector angio CT solution - Philips Spectral Angio CT suite - bringing the company’s breakthrough spectral CT imaging technology into an integrated hybrid angio CT suite.

  September 7, 2022

   · 

  6 min read
• Biotech Bay

  ASLAN Pharmaceuticals Presents New Data on Eblasakimab in Multiple Posters at the 31st Annual European Academy of Dermatology and Venereology (EADV) Congress

  ASLAN Pharmaceuticals announced the presentation of new eblasakimab data at the 2022 European Academy of Dermatology and Venereology annual congress in Milan, Italy.

  September 7, 2022

   · 

  8 min read
• Biotech Bay

  Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development

  Benchling, the R&D Cloud powering the biotechnology industry, launched the industry’s first full set of capabilities for designing, modeling, and studying both natural and chemically modified RNA in a single solution.

  September 7, 2022

   · 

  6 min read
• Business

  Stevanato Group and Gerresheimer AG Announce Collaboration on the Development of an Innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry

  Stevanato Group S.p.A. and Gerresheimer AG announce that they have jointly developed a high-end Ready-To-Use solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill® technology.

  September 7, 2022

   · 

  6 min read
• IRLAB to Present at Pareto Securities’ 13th Annual Healthcare Conference

  IRLAB Therapeutics AB announced that Richard Godfrey, CEO of IRLAB, will present at Pareto Securities’ 13th Annual Healthcare Conference in Stockholm, Sweden, on Thursday, September 8, 2022, at 11:00 am CEST.

  September 7, 2022

   · 

  1 min read